Trial · NCT00095628
Adverse events24
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
1 to 20 of 24
Download this page as JSON| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| other | Neutropenia | Investigations | Treatment (Ispinesib) | 14 | 20 | |
| other | Leukopenia | Investigations | Treatment (Ispinesib) | 15 | 20 | |
| other | Nausea | Gastrointestinal disorders | Treatment (Ispinesib) | 9 | 20 | |
| other | Lymphopenia | Investigations | Treatment (Ispinesib) | 9 | 20 | |
| other | Anemia | Blood and lymphatic system disorders | Treatment (Ispinesib) | 6 | 20 | |
| other | Hyponatremia | Metabolism and nutrition disorders | Treatment (Ispinesib) | 6 | 20 | |
| other | Fatigue | General disorders | Treatment (Ispinesib) | 5 | 20 | |
| other | Hypoalbuminemia | Metabolism and nutrition disorders | Treatment (Ispinesib) | 3 | 20 | |
| other | Injection site reaction | Skin and subcutaneous tissue disorders | Treatment (Ispinesib) | 3 | 20 | |
| other | Vomiting | Gastrointestinal disorders | Treatment (Ispinesib) | 3 | 20 | |
| other | Bone pain | Musculoskeletal and connective tissue disorders | Treatment (Ispinesib) | 1 | 20 | |
| serious | Anorexia | Metabolism and nutrition disorders | Treatment (Ispinesib) | 1 | 20 | 1 |
| serious | Cough | Respiratory, thoracic and mediastinal disorders | Treatment (Ispinesib) | 1 | 20 | 1 |
| serious | Dyspnea | Respiratory, thoracic and mediastinal disorders | Treatment (Ispinesib) | 2 | 20 | 2 |
| serious | Leukopenia | Investigations | Treatment (Ispinesib) | 1 | 20 | 1 |
| serious | Neutropenia | Investigations | Treatment (Ispinesib) | 1 | 20 | 1 |
| serious | Hyperkalemia | Metabolism and nutrition disorders | Treatment (Ispinesib) | 1 | 20 | 1 |
| serious | Pneumonia | Infections and infestations | Treatment (Ispinesib) | 1 | 20 | 1 |
| serious | Tracheal hemorrhage | Injury, poisoning and procedural complications | Treatment (Ispinesib) | 1 | 20 | 1 |
| serious | Edema face | General disorders | Treatment (Ispinesib) | 1 | 20 | 1 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT00095628/events